Science

Nicholas Hornstein: DYNAMIC out now with 5 year data Stage II colon cancer

Nicholas Hornstein/X

Mar 11, 2025, 08:32

Nicholas Hornstein: DYNAMIC out now with 5 year data Stage II colon cancer

Nicholas Hornstein, Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, shared an article by Jeanne Tie, et al. on X:

“DYNAMIC out now with 5 year data Stage II colon cancer using ctDNA adapted strategy.

Non-inferior statistically, but should note a clinically significant difference in outcomes among T4 patients (81% vs 70% RFS and 90% vs 80% OS). Have to question those NI margins…

Looks great on paper, but challenging to translate into clinical practice…”

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial.

Authors: Jeanne Tie, et al.

Nicholas Hornstein: DYNAMIC out now with 5 year data Stage II colon cancer

cancer Colon cancer ctDNA Donald and Barbara Zucker School of Medicine fight against cancer Global fight against cancer Jeanne Tie Nicholas Hornstein OncoDaily Oncology

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer